IP Library › Granted Patent US 10,501,463
Granted Patent B2
US 10,501,463 · App. 16/194,052 · Granted Dec 10, 2019

Antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones

Inventors: Jerôme Emile Georges Guillemont (Ande, FR); David Francis Alain Lançois (Louviers, FR); Magali Madeleine Simone Motte (Louviers, FR); Anil Koul (Edegem, BE); Wendy Mia Albert Balemans (Kalmthout, BE); Eric Pierre Alexandre Arnoult (Le Vaudreuil, FR)
Assignee: Janssen Sciences Ireland Unlimited Company
C07D471/04C07D487/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,501,463
App. No.
16/194,052
Granted
Dec 10, 2019
Kind
B2
Abstract

The present invention is related to novel compounds of formula (I) that inhibit the activity of the FabI enzyme which are therefore useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds.

Claims (6)

1. Compound

or a pharmaceutically acceptable salt thereof.

2. Compound

or a pharmaceutically acceptable salt thereof.

3. Compound

or a pharmaceutically acceptable salt thereof.

Assignments (1)
CHANGE OF NAME Recorded Mar 6, 2019
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 048523/0408 →